Please Wait
Applying Filters...

Information, Expiry & Status of FDA Orange Book Patents covering Sugammadex

Filters
×

filter

SUGAMMADEX SODIUM

filter

6949527

7265099

RE44733

filter

Y

Blank

filter

Y

Blank

filter

2020-08-07

2021-01-27

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

RE44733

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-01-27

Patent Use Code

U-1794

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

6949527

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-01-27

Patent Use Code

U-1795

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

6949527

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2021-01-27

Patent Use Code

U-1795

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE

Product Number

2

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7265099

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2020-08-07

Patent Use Code

U-1795

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

RE44733

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2021-01-27

Patent Use Code

U-1794

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF DRUG-INDUCED NEUROMUSCLUAR BLOCK

Product Number

1

Request an Update of Your Company Information, Events & Sales Content

US Patent Number

7265099

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2020-08-07

Patent Use Code

U-1795

Delist Requested

Application Number

22225

Patent Use Description

REVERSAL OF NEUROMUSCLUAR BLOCKAGE INDUCED BY ROCURONIUM BROMIDE OR VECURONIUM BROMIDE

Product Number

2

PharmaCompass >>

First
Previous
Next
Last